|
Special
Articles
|
|
2549
|
Editorial: Can
Serum Biomarker Assays Measure the Progression of Cartilage Degeneration
in Osteoarthritis?
|
|
|
A. Robin Poole
|
|
|
|
|
2553
|
Review: Glucocorticoids
and Rheumatoid Arthritis: Back to the Future?
|
|
|
Larry W. Moreland
and James R. O'Dell
|
|
|
|
|
2564
|
In Memoriam:
E. Carwile LeRoy, MD, 1933-2002
|
|
|
Richard M. Silver
|
| |
|
Rheumatoid
Arthritis
|
|
2565
|
Life-Threatening
Histoplasmosis Complicating Immunotherapy With Tumor Necrosis Factor
[alpha] Antagonists Infliximab and Etanercept
|
|
|
Jong-Hoon Lee, Nancy
R. Slifman, Sharon K. Gershon, Evelyne T. Edwards, William D. Schwieterman,
Jeffrey N. Siegel, Robert P. Wise, S. Lori Brown, John N. Udall, Jr.,
and M. Miles Braun
|
|
|
|
|
2571
|
Rapid and Complete
Resolution of Proteinuria Due to Renal Amyloidosis in a Patient With
Rheumatoid Arthritis Treated With Infliximab
|
|
|
Ori Elkayam, Philip
N. Hawkins, Helen Lachmann, Michael Yaron, and Dan Caspi
|
|
|
|
|
2574
|
Cachexia in Rheumatoid
Arthritis Is Not Explained by Decreased Growth Hormone Secretion
|
|
|
Laura C. Rall, Joseph
M. Walsmith, Laura Snydman, Seymour Reichlin, Johannes D. Veldhuis,
Joseph J. Kehayias, Leslie W. Abad, Nancy T. Lundgren, and Ronenn Roubenoff
|
|
|
|
|
2578
|
CD14+,CD16+ Blood
Monocytes and Joint Inflammation in Rheumatoid Arthritis
|
|
|
Norikuni Kawanaka,
Masahiro Yamamura, Tetsushi Aita, Yoshitaka Morita, Akira Okamoto, Masanori
Kawashima, Mitsuhiro Iwahashi, Akiko Ueno, Yasukazu Ohmoto, and Hirofumi
Makino
|
|
|
|
|
2587
|
Hypoxia-Induced
Production of Stromal Cell-Derived Factor 1 (CXCL12) and Vascular Endothelial
Growth Factor by Synovial Fibroblasts
|
|
|
Carol Hitchon, Keng
Wong, Guoping Ma, Jennifer Reed, David Lyttle, and Hani El-Gabalawy
|
|
|
|
|
2598
|
High Mobility
Group Box Chromosomal Protein 1: A Novel Proinflammatory Mediator in
Synovitis
|
|
|
R. Kokkola, E. Sundberg,
A.-K. Ulfgren, K. Palmblad, J. Li, H. Wang, L. Ulloa, H. Yang, X.-J.
Yan, R. Furie, N. Chiorazzi, K. J. Tracey, U. Andersson, and H. Erlandsson
Harris
|
|
|
|
|
2604
|
Inhibition of
Interleukin-1 but Not Tumor Necrosis Factor Suppresses Neovascularization
in Rat Models of Corneal Angiogenesis and Adjuvant Arthritis
|
|
|
Angela Coxon, Brad
Bolon, Juan Estrada, Stephen Kaufman, Sheila Scully, Alana Rattan, Diane
Duryea, Yi-Ling Hu, Karen Rex, Efrain Pacheco, Gwyneth Van, Debra Zack,
and Ulrich Feige
|
| |
|
Osteoarthritis
|
|
2613
|
Uncoupling of
Type II Collagen Synthesis and Degradation Predicts Progression of Joint
Damage in Patients With Knee Osteoarthritis
|
|
|
Patrick Garnero,
Xavier Ayral, Jean-Charles Rousseau, S. Christgau, Linda J. Sandell,
Maxime Dougados, and Pierre D. Delmas
|
|
|
|
|
2625
|
Significant Increases
in Serum and Plasma Concentrations of Matrix Metalloproteinases 3 and
9 in Patients With Rapidly Destructive Osteoarthritis of the Hip
|
|
|
Kensaku Masuhara,
Tsuyoshi Nakai, Katsuyuki Yamaguchi, Satoshi Yamasaki, and Yasuyuki
Sasaguri
|
|
|
|
|
2632
|
The Influence
of Alignment on Risk of Knee Osteoarthritis Progression According to
Baseline Stage of Disease
|
|
|
Rui Cerejo, Dorothy
D. Dunlop, September Cahue, David Channin, Jing Song, and Leena Sharma
|
|
|
|
|
2637
|
The In Situ Up-Regulation
of Chondrocyte Interleukin-1-Converting Enzyme and Interleukin-18 Levels
in Experimental Osteoarthritis Is Mediated by Nitric Oxide
|
|
|
Christelle Boileau,
Johanne Martel-Pelletier, Florina Moldovan, Jean-Yves Jouzeau, Patrick
Netter, Pamela T. Manning, and Jean-Pierre Pelletier
|
|
|
|
|
2648
|
Relative Messenger
RNA Expression Profiling of Collagenases and Aggrecanases in Human Articular
Chondrocytes In Vivo and In Vitro
|
|
|
Brigitte Bau, Pia
M. Gebhard, Jochen Haag, Thomas Knorr, Eckart Bartnik, and Thomas Aigner
|
|
|
|
|
2658
|
Human Intervertebral
Disc Aggrecan Inhibits Nerve Growth In Vitro
|
|
|
William E. B. Johnson,
Bruce Caterson, Stephen M. Eisenstein, Dianna L. Hynds, Diane M. Snow,
and Sally Roberts
|
| |
|
Systemic Lupus
Erythematosus and Autoimmunity
|
|
2665
|
Association of
Global Brain Damage and Clinical Functioning in Neuropsychiatric Systemic
Lupus Erythematosus
|
|
|
G. P. Th. Bosma,
H. A. M. Middlekoop, M. J. Rood, E. L. E. M. Bollen, T. W. J. Huizinga,
and M. A. van Buchem
|
|
|
|
|
2673
|
An Open Study
of B Lymphocyte Depletion in Systemic Lupus Erythematosus
|
|
|
Maria J. Leandro,
Jonathan C. Edwards, Geraldine Cambridge, Michael R. Ehrenstein, and
David A. Isenberg
|
|
|
|
|
2678
|
Familiality and
Co-Occurrence of Clinical Features of Systemic Lupus Erythematosus
|
|
|
Betty P. Tsao, Jennifer
M. Grossman, Gabriela Riemekasten, Noel Strong, Jatinderpal Kalsi, Daniel
J. Wallace, Chung-Jen Chen, Chak S. Lau, Ellen M. Ginzler, Rose Goldstein,
Kenneth C. Kalunian, John B. Harley, Frank C. Arnett, Bevra H. Hahn,
and Rita M. Cantor
|
|
|
|
|
2686
|
Antibodies to
High-Density Lipoprotein and [beta]2-Glycoprotein I Are Inversely Correlated
With Paraoxonase Activity in Systemic Lupus Erythematosus and Primary
Antiphospholipid Syndrome
|
|
|
J. Delgado Alves,
P. R. J. Ames, S. Donohue, L. Stanyer, J. Noorouz-Zadeh, C. Ravirajan,
and D. A. Isenberg
|
|
|
|
|
2695
|
Association of
Autoantibodies to Nuclear Lamin B1 With Thromboprotection in Systemic
Lupus Erythematosus: Lack of Evidence for a Direct Role of Lamin B1
in Apoptotic Blebs
|
|
|
Melanie Dieude,
Jean-Luc Senecal, Joyce Rauch, John G. Hanly, Paul Fortin, Nathalie
Brassard, and Yves Raymond
|
| |
|
Childhood
Arthritis
|
|
2708
|
The Early Pattern
of Joint Involvement Predicts Disease Progression in Children With Oligoarticular
(Pauciarticular) Juvenile Rheumatoid Arthritis
|
|
|
Mohammad J. Al-Matar,
Ross E. Petty, Lori B. Tucker, Peter N. Malleson, Maria-Louise Schroeder,
and David A. Cabral
|
|
|
|
|
2716
|
Evidence for
Linkage of HLA Loci in Juvenile Idiopathic Oligoarthritis: Independent
Effects of HLA-A and HLA-DRB1
|
|
|
Eleftheria Zeggini,
Rachelle P. Donn, William E. R. Ollier, Wendy Thomson, and The British
Paediatric Rheumatology Study Group
|
|
|
|
|
2721
|
Proinflammatory
Responses to Self HLA Epitopes Are Triggered by Molecular Mimicry to
Epstein-Barr Virus Proteins in Oligoarticular Juvenile Idiopathic Arthritis
|
|
|
Margherita Massa,
Federica Mazzoli, Patrizia Pignatti, Fabrizio De Benedetti, Maristella
Passalia, Stefania Viola, Rodrigo Samodal, Antonio La Cava, Francesca
Giannoni, W. Ollier, Alberto Martini, and Salvatore Albani
|
| |
|
Sjogren's Syndrome
|
|
2730
|
Involvement of
the Interferon-[gamma]-Induced T Cell-Attracting Chemokines, Interferon-[gamma]-Inducible
10-kd Protein (CXCL10) and Monokine Induced by Interferon-[gamma] (CXCL9),
in the Salivary Gland Lesions of Patients With Sjogren's Syndrome
|
|
|
Noriyoshi Ogawa,
Li Ping, Li Zhenjun, Yukiko Takada, and Susumu Sugai
|
| |
|
Systemic
Sclerosis
|
|
2742
|
Identification
of an Immunodominant Epitope on RNA Polymerase III Recognized by Systemic
Sclerosis Sera: Application to Enzyme-Linked Immunosorbent Assay
|
|
|
Masataka Kuwana,
Kyoko Kimura, and Yutaka Kawakami
|
|
|
|
|
2748
|
Halofuginone
Inhibition of COL1A2 Promoter Activity Via a c-Jun-Dependent Mechanism
|
|
|
Tracy L. McGaha,
Takao Kodera, Harry Spiera, Alexandru C. Stan, Mark Pines, and Constantin
A. Bona
|
| |
|
Polymyositis
|
|
2762
|
Symptomatic Macroglossia
and Tongue Myositis in Polymyositis: Treatment With Corticosteroids
and Intravenous Immunoglobulin
|
|
|
E. Chauvet, L. Sailler,
M. Carreiro, J. R. Paoli, P. Arrue, L. Astudillo, F. Oksmann, M. B.
Delisle, and Ph. Arlet
|
| |
|
Gout
|
|
2765
|
Activation of
Melanocortin Type 3 Receptor as a Molecular Mechanism for Adrenocorticotropic
Hormone Efficacy in Gouty Arthritis
|
|
|
Stephen J. Getting,
Helen C. Christian, Roderick J. Flower, and Mauro Perretti
|
| |
|
Psoriatic Arthritis
|
|
2776
|
Alefacept Treatment
in Psoriatic Arthritis: Reduction of the Effector T Cell Population
in Peripheral Blood and Synovial Tissue Is Associated With Improvement
of Clinical Signs of Arthritis
|
|
|
Maarten C. Kraan,
Arno W. R. van Kuijk, Huibert J. Dinant, Amber Y. Goedkoop, Tom J. M.
Smeets, Menno A. de Rie, Ben A. C. Dijkmans, Akshay K. Vaishnaw, Jan
D. Bos, and Paul P. Tak
|
| |
|
Periodic
Fever Syndromes
|
|
2785
|
Reduced MEFV
Messenger RNA Expression in Patients With Familial Mediterranean Fever
|
|
|
Cecile Notarnicola,
Marie-Noelle Didelot, Isabelle Kone-Paut, Fabienne Seguret, Jacques
Demaille, and Isabelle Touitou
|
|
|
|
|
2794
|
Lack of Isoprenoid
Products Raises Ex Vivo Interleukin-1[beta] Secretion in Hyperimmunoglobulinemia
D and Periodic Fever Syndrome
|
|
|
Joost Frenkel, Ger
T. Rijkers, Saskia H. L. Mandey, Sandra W. M. Buurman, Sander M. Houten,
Ronald J. A. Wanders, Hans R. Waterham, and Wietse Kuis
|
| |
|
Radiologic
Vignettes
|
|
2804
|
Radiographic
Healing With Sustained Clinical Remission in a Patient With Rheumatoid
Arthritis Receiving Methotrexate Monotherapy
|
|
|
Siegfried Wassenberg
and Rolf Rau
|
|
|
|
|
2808
|
Osteoid Osteoma
of the Capitate
|
|
|
Andreas Schindler,
Juerg Hodler, Beat A. Michel, and Pius Bruehlmann
|
| |
|
Concise
Communications
|
|
2811
|
Absence of Inducible
Retroviruses From Synovial Fibroblasts and Synovial Fluid Cells of Patients
With Rheumatoid Arthritis
|
|
|
Christian A. Seemayer,
Stefan A. Kolb, Michel Neidhart, Shiro Ohshima, Renate E. Gay, Beat
A. Michel, Steffen Gay, Jurg Boni, and Jorg Schupbach
|
|
|
|
|
2814
|
Magnetic Resonance
Imaging as a Predictor of Progressive Joint Destruction in Neuropathic
Joint Disease
|
|
|
Adam S. Greenstein,
Helena Marzo-Ortega, Paul Emery, Philip O'Connor, and Dennis McGonagle
|
| |
|
Clinical
Image
|
|
2816
|
Crystal-Induced
Arthritis Mimicking Rheumatoid Arthritis in a Patient With Monoclonal
Gammopathy
|
|
|
H. Aarset, J. Dekker,
S.-H. Brorson, and G. Husby
|
| |
|
Letters
|
|
2817
|
Blocking Tumor
Necrosis Factor Inhibits Radiographic Damage Even in Patients Who Show
Minimal or No Clinical Improvement: Comment on the Concise Communication
by Boers
|
|
|
Peter E. Lipsky,
David T. Felson, and Ravinder N. Maini
|
|
|
|
|
2818
|
Reply
|
|
|
Maarten Boers
|
|
|
|
|
2820
|
Comment on the
Reply by Boers
|
|
|
Peter E. Lipsky
and Ravinder N. Maini
|
|
|
|
|
2821
|
Case Series of
Selective Anti-Tumor Necrosis Factor [alpha] Therapy Using Infliximab
in Patients With Nonresponsive Chronic HLA-B27-Associated Anterior Uveitis:
Comment on the Articles by Brandt et al
|
|
|
Yosuf El-Shabrawi
and Josef Hermann
|
|
|
|
|
2822
|
Reply
|
|
|
Jurgen Braun and
Joachim Sieper
|
|
|
|
|
2824
|
Is Expression
of Intracellular Citrullinated Proteins in Synovial Tissue Specific
for Rheumatoid Arthritis? Comment on the Article by Baeten et al
|
|
|
T. J. M. Smeets,
E. R. Vossenaar, W. J. van Venrooij, and P. P. Tak
|
|
|
|
|
2826
|
Reply
|
|
|
Dominique Baeten,
Eric M. Veys, and Filip De Keyser
|
|
|
|
|
2827
|
Is Acquired C1
Inhibitor Deficiency Associated With Lupus a Distinct Disease Entity?
Comment on the Article by Cacoub et al
|
|
|
Aamir Aslam and
Siraj A. Misbah
|
|
|
|
|
2828
|
Reply
|
|
|
Patrice Cacoub and
Veronique Fremeaux-Bacchi
|
|
|
|
|
2828
|
Is the Sp1 Polymorphism
in the COL1A1 Gene a Risk Factor for Postmenopausal Osteoporosis? Comment
on the Article by Keen et al
|
|
|
K. Zajickova, I.
ofkova, and M. Hill
|
|
|
|
|
2829
|
Mutations of
Bone Morphogenetic Protein Receptor Type II Are Not Found in Patients
With Pulmonary Hypertension and Underlying Connective Tissue Diseases
|
|
|
Monty B. Tew, Frank
C. Arnett, John D. Reveille, and Filemon K. Tan
|
|
|
|
|
Erratum
|
|
2830
|
Author's Name
Omitted From Article by Leask et al (Arthritis Rheum, July 2002)
|
| |
|
ACR
Announcements
|
| 19A
|
|
|
Cover image: The
figure on the cover (from Wassenberg and Rau, page 2805) shows sequential
radiographs of a metatarsophalangeal joint of a patient with rheumatoid
arthritis treated with methotrexate. The first radiograph was obtained
in 1997, and the second in 2000. As these radiographs indicate, effective
disease-modifying antirheumatic drug therapy can have a significant
impact on the erosive process, leading not only to cessation, but to
repair. These findings are important with regard to the discussion of
the effect of various disease-modifying antirheumatic drugs on tissue
destruction and suggest that healing and remodeling may also occur with
these agents.
|
|
|
|
